WEIGAO GROUP Repurchases 88,400 H Shares for HK$0.29 Million, Lifts Treasury Stock to 67.61 Million Shares

Bulletin Express10-15

Shandong Weigao Group Medical Polymer Company Limited (abbrev. WEIGAO GROUP) disclosed a repurchase of 88,400 H shares on 15 October 2026. The shares were bought on the Hong Kong Stock Exchange at prices ranging from HK$3.295 to HK$3.34 per share, representing a volume-weighted average cost of HK$3.33. The total cash outlay amounted to HK$0.29 million.

Following the transaction, WEIGAO GROUP’s issued share capital (excluding treasury shares) declined marginally by 0.002 % to 4.45 billion shares, while the company’s treasury stock increased to 67.61 million shares. The overall issued share count, inclusive of treasury shares, remains unchanged at 4.52 billion.

The buyback forms part of a broader mandate approved by shareholders on 29 May 2026, which authorises repurchases of up to 446.46 million shares. To date, the company has repurchased 10.28 million shares under this authority, equivalent to 2.30 % of the issued share capital at the time the mandate was granted.

In line with Hong Kong listing rules, WEIGAO GROUP is subject to a 30-day moratorium on new share issues or treasury share disposals, effective until 15 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment